NCT06301425
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Peking University People's Hospital Beijing, China
Clinical trial condition
Neoplasm, Residual
Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.
207 public trials
79 recruiting studies
Neoplasm, Residual trial results
NCT06109233
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- The First Hospital of Jilin University Changchun, Jilin, China
Recruiting
Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
NCT06463717
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China
NCT06198868
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Jiangsu Cancer Institute & Hospital Nanjing, Jiangsu, China
NCT06158269
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China
NCT06066905
- Conditions
- AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
NCT05623267
- Conditions
- Limited Stage Small Cell Lung Cancer, Neoplasm, Residual, Neoplasms, +3 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Recruiting
Minimally Residual of Esophageal Cancer 001
NCT05952661
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Carcinoma, +12 more
- Locations
-
- Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
NCT05408897
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +11 more
- Locations
-
- Peking University People'S Hospital Beijing, Beijing Municipality, China
Not yet recruiting
CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia
NCT07841002
- Conditions
- Acute Myeloid Leukemia (AML), Cytokine Release Syndrome, Disease Attributes, +16 more
- Locations
-
- Chinese PLA General Hospital, Beijing, Beijing 100853 Beijing, China